News
OPS-0015 · 2026-11-16Clinical Trial Supplies - Global Strategic Business Report: Secure Share of a US$3.7 Billion Market by 2030 as Almac, Catalent, Marken and Thermo Fisher Disrupt Decentralized Trial Logistics
Boost ROI with AI forecasting, real-time tracking, cloud inventory, automation and direct-to-patient logistics that reduce waste, prevent delays and strengthen trial resilience.
Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "Clinical Trial Supplies - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
Global Clinical Trial Supplies Market Projected to Reach US$3.7 Billion by 2030
The global clinical trial supplies market, estimated at US$2.8 billion in 2024, is forecast to reach US$3.7 billion by 2030. The market is expected to expand at a compound annual growth rate of 4.7% between 2024 and 2030, supported by the globalization of clinical research, adoption of decentralized trial models, advances in personalized medicine and increasing use of digital supply chain technologies.
The comprehensive market report examines clinical trial supplies industry trends, competitive conditions, growth drivers and forecasts across major segments and geographic markets. It also evaluates global tariff developments and their effects on sourcing, transportation, operating costs, supply chain resilience and regional market strategies.
Clinical Trial Supply Chains Become Increasingly Strategic
Clinical trial supplies are essential to the timely and compliant execution of pharmaceutical, biologic and medical device studies. Investigational products, placebos, diagnostic kits, ancillary materials and protective equipment must be packaged, transported, stored and delivered under tightly controlled conditions.
Supply requirements are especially complex for multinational Phase II and Phase III studies involving multiple research sites, regulatory jurisdictions and distribution partners. Temperature-sensitive biologics, advanced therapies and other high-value investigational products require validated cold-chain infrastructure, specialized packaging and continuous environmental monitoring. Inventory shortages, shipment delays or temperature excursions can affect patient dosing schedules, regulatory compliance, data integrity and trial completion timelines.
Technology Transforms Clinical Trial Supply Management
Digital technologies are improving visibility, forecasting and risk management throughout the clinical trial supply chain. Radio frequency identification, Internet of Things sensors and connected monitoring systems provide real-time information on shipment location, temperature, humidity and handling conditions.
Cloud-based clinical supply platforms support inventory planning, demand forecasting and coordination among sponsors, contract research organizations, manufacturers, depots and trial sites. Artificial intelligence and machine learning are also being applied to historical and operational data to optimize supply strategies, anticipate demand and identify potential disruptions. Automation in packaging, labeling and warehousing is helping organizations improve accuracy, accelerate fulfillment and reduce operational risk.
Decentralized Trials and Personalized Medicine Reshape Logistics
Decentralized clinical trials are increasing demand for direct-to-patient logistics, flexible packaging and secure last-mile distribution. Shipping clinical supplies to patients requires close coordination of consent, privacy, scheduling, product stability and country-specific regulatory obligations. These requirements are encouraging investment in integrated logistics networks and technology-enabled tracking platforms.
Personalized medicine is creating additional supply chain complexity, particularly in oncology and rare disease research. Patient-specific therapies are often manufactured in small batches and managed under strict chain-of-identity and chain-of-custody protocols. Successful delivery depends on precise synchronization among manufacturing facilities, clinical sites, laboratories, logistics providers and patients.
Clinical Trial Supplies Market Growth Drivers
- Expansion of multinational clinical trials and the pursuit of more diverse patient populations
- Growth in decentralized, hybrid and patient-centric research models
- Rising development activity involving biologics, cell and gene therapies and personalized treatments
- Increasing demand for temperature-controlled packaging, storage and transportation
- Adoption of real-time monitoring, cloud-based inventory systems and AI-supported forecasting
- Greater emphasis on regulatory compliance, business continuity and supply chain resilience
Market Scope and Segment Analysis
The report analyzes the clinical trial supplies market by study phase, end use and geography. Phase-based coverage includes Phase I, Phase II, Phase III and other phases. End-use categories include pharmaceutical, biologics, medical devices and other applications.
Geographic coverage encompasses the United States, Canada, Japan, China, Europe, Asia-Pacific and the Rest of World. European analysis includes France, Germany, Italy, the United Kingdom and the Rest of Europe, with additional regional insights covering Latin America, the Middle East and Africa.
The Phase I segment is projected to reach US$532.1 million by 2030, advancing at a CAGR of 5.2%. The Phase II segment is forecast to grow at a CAGR of 4.5% over the analysis period. The United States market was valued at US$769.7 million in 2024, while China is projected to reach US$587.4 million by 2030, expanding at a CAGR of 4.6%.
Domain Expert Insights
The report tracks annual sales, market forecasts, regional performance, segment growth and competitive positioning through 2030. Its analysis incorporates trade policy developments, economic uncertainty, sourcing changes and structural shifts in globalization. Historical data and updated projections support assessment of long-term market direction and emerging revenue opportunities.
The June 2025 edition evaluates tariff negotiations involving more than 180 countries and examines potential consequences for sourcing, cross-border distribution and geographic realignment. Revised forecasts account for tariff effects, economic volatility and evolving trade relationships. The report also reviews population trends, urbanization, innovation, process improvements and emerging technologies influencing the clinical trial supplies market.
Competitive Landscape
The report provides profiles and competitive intelligence covering 33 clinical trial supply companies. Featured organizations include Almac Group, Bilcare Limited, Biocair, Capsugel, Catalent, CSM-Clingen, Eurofins Scientific, Infosys, KLIFO, Marken, Metrics Contract Services, N-Side, O&M Movianto, Parexel International, PCI Services, PRA Health Sciences, Seveillar Clinical Trial Supplies, SIRO Clinpharm, Thermo Fisher Scientific and UDG Healthcare.
Competitive analysis includes updated market share estimates, geographic presence and positioning of major global participants. Companies are assessed across strong, active, niche and limited market positions, enabling readers to evaluate the evolving competitive environment and identify potential partnerships, investments and expansion opportunities.
Key Report Benefits
- Independent clinical trial supplies market forecasts from 2024 through 2030
- Detailed analysis of leading regions, countries, study phases and end-use sectors
- Evaluation of decentralized trials, personalized medicine and digital supply chain innovation
- Assessment of tariffs, trade negotiations and sourcing disruptions
- Competitive profiles and market positioning of prominent industry participants
- Actionable intelligence supporting strategic planning and revenue development
- Complimentary updates for one year, including revised tariff and trade impact analysis
The report addresses how the global clinical trial supplies market is expected to evolve through 2030, which segments and regions offer the strongest growth prospects, how regulatory and trade developments may affect market performance, and which companies are positioned to benefit from changing clinical research and logistics requirements.
Key Attributes:
| Report Attribute | Details |
|---|---|
| No. of Pages | 174 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $2.8 Billion |
| Forecasted Market Value (USD) by 2030 | $3.7 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/dmhmus
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
